KLINICKÁ FARMAKOLOGIE A FARMACIE / Klin Farmakol Farm. 2025;39(4):236-240 / www.klinickafarmakologie.cz 240 PŘEHLEDOVÉ ČLÁNKY Vazoaktivní léky v léčbě erektilní dysfunkce: současné koncepty 5. Valicenti RK, Bissonette EA, Chen C, et al. Longitudinal comparison of sexual function after 3-dimensional conformal radiation therapy or prostate brachytherapy. J Urol. 2002;168(6):2499-2504. 6. Vlachopoulos CV, Terentes‑Printzios DG, Ioakeimidis NK, et al. Prediction of cardiovascular events and all‑cause mortality with erectile dysfunction: a systematic review and meta‑analysis of cohort studies. Circ Cardiovasc Qual Outcomes. 2013;6(1):99-109. 7. Hodges LD, Kirby M, Solanki J, et al. The temporal relationship between erectile dysfunction and cardiovascular disease. Int J Clin Pract. 2007;61(12):2019-2025. 8. Gandaglia G, Briganti A, Jackson G, et al. A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol. 2014;65(5):968-978. 9. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):596-646. 10. Kloner RA, Burnett AL, Miner M, et al. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health. J Sex Med. 2024;30;21(2):90-116. 11. Maiorino MI, Bellastella G, Esposito K. Lifestyle modifications and erectile dysfunction: what can be expected? Asian J Androl. 2015;17(1):5-10. 12. Hatzimouratidis K, Salonia A, Adaikan G, et al. Pharmacotherapy for erectile dysfunction: recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016;13(4):465-488. 13. Hatzimouratidis K, Hatzichristou DG. A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient? Drugs. 2005;65(12):1621-1650. 14. Goldstein I, Lue TF, Padma‑Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med. 1998;338(20):1397-1404. 15. Moncada I, Jara J, Subirá D, et al. Efficacy of sildenafil citrate at 12 hours after dosing: re‑exploring the therapeutic window. Eur Urol. 2004;46(3):357-361. 16. SmPC jednotlivých léčivých přípravků, dostupné z Databáze léků. Státní ústav pro kontrolu léčiv [online], SÚKL: ©2035 [cit. 25.05.2025]. Dostupné na: https://www.sukl.cz/. 17. Curran M, Keating G. Tadalafil. Drugs. 2003;63(20): 22032214. 18. Capogrosso P, Ventimiglia E, Boeri L, et al. Time of onset of vardenafil orodispersible tablet in a real-life setting – looking beyond randomized clinical trials. Expert Rev Clin Pharmacol. 2017;10(3):339-344. 19. Chung E, Broc GB. A state of art review on vardenafil in men with erectile dysfunction and associated underlying diseases. Expert Opin Pharmacother. 2011;12(8):1341-1348. 20. Corona G, Rastrelli G, Burri A, et al. The safety and efficacy of Avanafil, a new 2(nd) generation PDE5i: comprehensive review and meta‑analysis. Expert Opin Drug Saf. 2016;15(2):237-247. 21. Coombs PG, Heck M, Guhring P, et al. A review of outcomes of an intracavernosal injection therapy programme. BJU Int. 2012;110(11):1787-1791. 22. Eardley I, Donatucci C, Corbin J, et al. Pharmacotherapy for erectile dysfunction. J Sex Med. 2010;7(1 Pt 2):524-540. 23. Lakin MM, Montague DK, VanderBrug Medendorp S, et al. Intracavernous injection therapy: analysis of results and complications. J Urol. 1990;143(6):1138-1141. … nenechte si ujít aktuální informace o možnostech medicínského vzdělávání FACEBOOK https://www.facebook.com/ SolenMedicalEducation/ @SolenMedicalEducation LINKEDIN https://www.linkedin.com/ company/solen-medical-education/ #solenmedicaleducation INSTAGRAM https://www.instagram.com/ solen_cz/ @solen_cz ODEMČENÉ AKTUÁLNÍ ČLÁNKY PŘEHLED O VZDĚLÁVACÍCH AKCÍCH UPOZORNĚNÍ NA ZVÝHODNĚNÉ CENY SOUTĚŽE O VSTUPENKY NA KONGRESY INFORMACE O ON LINE KURZECH NOVINKY V E SHOPU … a mnoho dalšího
RkJQdWJsaXNoZXIy NDA4Mjc=